Dengue Virus Subverts Host Innate Immunity by Targeting Adaptor Protein MAVS

Journal of Virology

Volumn 90, Issue 16, 2016, Pages 7219-7230

  He, Zhenjian ^a   Zhu, Xun ^a,b   Wen, Weitao ^a,b   Yuan, Jie ^a,b   Hu, Yiwen ^a,b   Chen, Jiahui ^a,b   An, Shu ^a,b   Dong, Xinhuai ^a,b   Lin, Cuiji ^a,b   Yu, Jianchen ^a,b   Wu, Jueheng ^a,b   Yang, Yi ^a,b   Cai, Junchao ^a,b   Li, Jun ^a,b   Li, Mengfeng ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON REGULATORY FACTOR 3; NONSTRUCTURAL PROTEIN 4A; PROTEIN MAVS; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; ANTIVIRUS AGENT; MESSENGER RNA; NS4A PROTEIN, DENGUE VIRUS; PROTEIN BINDING; RARRES3 PROTEIN, HUMAN; RETINOIC ACID RECEPTOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN; VIRAL PROTEIN; VISA PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; DENGUE VIRUS; EMBRYO; ENDOPLASMIC RETICULUM MEMBRANE; HOST CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; INTERFERON PRODUCTION; MITOCHONDRIAL MEMBRANE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DENGUE; ENDOPLASMIC RETICULUM; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HEK293 CELL LINE; HELA CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; IMMUNOPRECIPITATION; METABOLISM; MONOCYTE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VIROLOGY; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIVIRAL AGENTS; BLOTTING, WESTERN; CELLS, CULTURED; DENGUE; DENGUE VIRUS; ENDOPLASMIC RETICULUM; FLUORESCENT ANTIBODY TECHNIQUE; HEK293 CELLS; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; IMMUNOENZYME TECHNIQUES; IMMUNOPRECIPITATION; INTERFERON REGULATORY FACTOR-3; INTERFERON TYPE I; MONOCYTES; NF-KAPPA B; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84982237073     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00221-16     Document Type: Article

References (50)

1. Clyde K, Kyle JL, Harris E. 2006. Recent advances in deciphering viral and host determinants of dengue virus replication and pathogenesis. J Virol 80:11418-11431. http://dx.doi.org/10.1128/JVI.01257-06.
2. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, Hunsperger E, Kroeger A, Margolis HS, Martinez E, Nathan MB, Pelegrino JL, Simmons C, Yoksan S, Peeling RW. 2010. Dengue: a continuing global threat. Nat Rev Microbiol 8:S7-S16. http://dx.doi.org/10.1038/nrmicro2460.
3. Perera R, Kuhn RJ. 2008. Structural proteomics of dengue virus. Curr Opin Microbiol 11:369-377. http://dx.doi.org/10.1016/j.mib.2008.06.004.
4. Sen GC. 2001. Viruses and interferons. Annu Rev Microbiol 55:255-281. http://dx.doi.org/10.1146/annurev.micro.55.1.255.
5. Samuel CE. 2001. Antiviral actions of interferons. Clin Microbiol Rev 14:778-809. http://dx.doi.org/10.1128/CMR.14.4.778-809.2001.
6. Yoneyama M, Fujita T. 2009. RNA recognition and signal transduction by RIG-I-like receptors. Immunol Rev 227:54-65. http://dx.doi.org/10.1111/j.1600-065X.2008.00727.x.
7. Seth RB, Sun L, Ea CK, Chen ZJ. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669-682. http://dx.doi.org/10.1016/j.cell.2005.08.012.
8. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S. 2005. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol 6:981-988. http://dx.doi.org/10.1038/ni1243.
9. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19:727-740. http://dx.doi.org/10.1016/j.molcel.2005.08.014.
10. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172. http://dx.doi.org/10.1038/nature04193.
11. Moore CB, Ting JP. 2008. Regulation of mitochondrial antiviral signaling pathways. Immunity 28:735-739. http://dx.doi.org/10.1016/j.immuni.2008.05.005.
12. Morrison J, Aguirre S, Fernandez-Sesma A. 2012. Innate immunity evasion by dengue virus. Viruses 4:397-413. http://dx.doi.org/10.3390/v4030397.
13. Perry ST, Prestwood TR, Lada SM, Benedict CA, Shresta S. 2009. Cardif-mediated signaling controls the initial innate response to dengue virus in vivo. J Virol 83:8276 -8281. http://dx.doi.org/10.1128/JVI.00365-09.
14. Rodriguez-Madoz JR, Belicha-Villanueva A, Bernal-Rubio D, Ashour J, Ayllon J, Fernandez-Sesma A. 2010. Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex. J Virol 84:9760-9774. http://dx.doi.org/10.1128/JVI.01051-10.
15. Diamond MS, Roberts TG, Edgil D, Lu B, Ernst J, Harris E. 2000. Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 74:4957-4966. http://dx.doi.org/10.1128/JVI.74.11.4957-4966.2000.
16. Diamond MS, Harris E. 2001. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology 289:297-311. http://dx.doi.org/10.1006/viro.2001.1114.
17. Munoz-Jordan JL, Laurent-Rolle M, Ashour J, Martinez-Sobrido L, Ashok M, Lipkin WI, Garcia-Sastre A. 2005. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 79:8004-8013. http://dx.doi.org/10.1128/JVI.79.13.8004-8013.2005.
18. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A. 2003. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 100:14333-14338. http://dx.doi.org/10.1073/pnas.2335168100.
19. Ho LJ, Hung LF, Weng CY, Wu WL, Chou P, Lin YL, Chang DM, Tai TY, Lai JH. 2005. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J Immunol 174:8163-8172. http://dx.doi.org/10.4049/jimmunol.174.12.8163.
20. Jones M, Davidson A, Hibbert L, Gruenwald P, Schlaak J, Ball S, Foster GR, Jacobs M. 2005. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. J Virol 79:5414-5420. http://dx.doi.org/10.1128/JVI.79.9.5414-5420.2005.
21. Mazzon M, Jones M, Davidson A, Chain B, Jacobs M. 2009. Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis 200: 1261-1270. http://dx.doi.org/10.1086/605847.
22. Ashour J, Laurent-Rolle M, Shi PY, Garcia-Sastre A. 2009. NS5 of dengue virus mediates STAT2 binding and degradation. J Virol 83:5408-5418. http://dx.doi.org/10.1128/JVI.02188-08.
23. Yu CY, Chang TH, Liang JJ, Chiang RL, Lee YL, Liao CL, Lin YL. 2012. Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog 8:e1002780. http://dx.doi.org/10.1371/journal.ppat.1002780.
24. Aguirre S, Maestre AM, Pagni S, Patel JR, Savage T, Gutman D, Maringer K, Bernal-Rubio D, Shabman RS, Simon V, Rodriguez-Madoz JR, Mulder LC, Barber GN, Fernandez-Sesma A. 2012. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog 8:e1002934. http://dx.doi.org/10.1371/journal.ppat.1002934.
25. Yamagata T, Nishida J, Tanaka S, Sakai R, Mitani K, Yoshida M, Taniguchi T, Yazaki Y, Hirai H. 1996. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol Cell Biol 16:1283-1294. http://dx.doi.org/10.1128/MCB.16.4.1283.
26. Zhou JM, Tang YX, Fang DY, Zhou JJ, Liang Y, Guo HY, Jiang LF. 2006. Secreted expression and purification of dengue 2 virus full-length nonstructural glycoprotein NS1 in Pichia pastoris. Virus Genes 33:27-32. http://dx.doi.org/10.1007/s11262-005-0036-6.
27. Liang Z, Wu S, Li Y, He L, Wu M, Jiang L, Feng L, Zhang P, Huang X. 2011. Activation of Toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-beta in cultured hepatoma cells. PLoS One 6:e23346. http://dx.doi.org/10.1371/journal.pone.0023346.
28. Lambeth CR, White LJ, Johnston RE, de Silva AM. 2005. Flow cytometry-based assay for titrating dengue virus. J Clin Microbiol 43:3267-3272. http://dx.doi.org/10.1128/JCM.43.7.3267-3272.2005.
29. Kochs G, Garcia-Sastre A, Martinez-Sobrido L. 2007. Multiple antiinterferon actions of the influenza A virus NS1 protein. J Virol 81:7011-7021. http://dx.doi.org/10.1128/JVI.02581-06.
30. Martinez-Sobrido L, Zuniga EI, Rosario D, Garcia-Sastre A, de la Torre JC. 2006. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 80:9192-9199. http://dx.doi.org/10.1128/JVI.00555-06.
31. Salio M, Ghadbane H, Dushek O, Shepherd D, Cypen J, Gileadi U, Aichinger MC, Napolitani G, Qi X, van der Merwe PA, Wojno J, Veerapen N, Cox LR, Besra GS, Yuan W, Cresswell P, Cerundolo V. 2013. Saposins modulate human invariant natural killer T cells selfreactivity and facilitate lipid exchange with CD1d molecules during antigen presentation. Proc Natl Acad Sci U S A 110:E4753-E4761 http://dx.doi.org/10.1073/pnas.1310050110.
32. Wu J, Jiang Y, Yang W, He Z, Meng S, Zhang Q, Lin M, Zhang H, Li W, Yang Y, Jia Y, Qian L, Lu D, Cai W, Luo G, Wang Y, Zhu X, Li M. 2012. Dual function of RGD-modified VEGI-192 for breast cancer treatment. Bioconjug Chem 23:796 -804. http://dx.doi.org/10.1021/bc2006576.
33. Lee S, Tsai YC, Mattera R, Smith WJ, Kostelansky MS, Weissman AM, Bonifacino JS, Hurley JH. 2006. Structural basis for ubiquitin recognition and autoubiquitination by Rabex-5. Nat Struct Mol Biol 13:264-271. http://dx.doi.org/10.1038/nsmb1064.
34. Wieckowski MR, Giorgi C, Lebiedzinska M, Duszynski J, Pinton P. 2009. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat Protoc 4:1582-1590. http://dx.doi.org/10.1038/nprot.2009.151.
35. Varga ZT, Ramos I, Hai R, Schmolke M, Garcia-Sastre A, Fernandez-Sesma A, Palese P. 2011. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog 7:e1002067. http://dx.doi.org/10.1371/journal.ppat.1002067.
36. Varga ZT, Grant A, Manicassamy B, Palese P. 2012. Influenza virus protein PB1-F2 inhibits the induction of type I interferon by binding to MAVS and decreasing mitochondrial membrane potential. J Virol 86: 8359-8366. http://dx.doi.org/10.1128/JVI.01122-12.
37. Vance JE. 1990. Phospholipid synthesis in a membrane fraction associated with mitochondria. J Biol Chem 265:7248-7256.
38. Lebiedzinska M, Szabadkai G, Jones AW, Duszynski J, Wieckowski MR. 2009. Interactions between the endoplasmic reticulum, mitochondria, plasma membrane and other subcellular organelles. Int J Biochem Cell Biol 41:1805-1816. http://dx.doi.org/10.1016/j.biocel.2009.02.017.
39. Miller S, Kastner S, Krijnse-Locker J, Buhler S, Bartenschlager R. 2007. The non-structural protein 4A of dengue virus is an integral membrane protein inducing membrane alterations in a 2K-regulated manner. J Biol Chem 282:8873-8882. http://dx.doi.org/10.1074/jbc.M609919200.
40. Loo YM, Gale M, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34:680-692. http://dx.doi.org/10.1016/j.immuni.2011.05.003.
41. Park MS, Shaw ML, Munoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, Garcia-Sastre A, Basler CF. 2003. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDVVprotein and the Nipah virus V, W, andCproteins. J Virol 77:1501-1511. http://dx.doi.org/10.1128/JVI.77.2.1501-1511.2003.
42. Charoenthongtrakul S, Gao L, Parvatiyar K, Lee D, Harhaj EW. 2013. RING finger protein 11 targets TBK1/IKKi kinases to inhibit antiviral signaling. PLoS One 8:e53717. http://dx.doi.org/10.1371/journal.pone .0053717.
43. Liu SY, Sanchez DJ, Cheng G. 2011. New developments in the induction and antiviral effectors of type I interferon. Curr Opin Immunol 23:57-64. http://dx.doi.org/10.1016/j.coi.2010.11.003.
44. Chang TH, Liao CL, Lin YL. 2006. Flavivirus induces interferon-beta gene expression through a pathway involving RIG-I-dependent IRF-3 and PI3K-dependent NF-kappaB activation. Microbes Infect 8:157-171. http: //dx.doi.org/10.1016/j.micinf.2005.06.014.
45. Rodriguez-Madoz JR, Bernal-Rubio D, Kaminski D, Boyd K, Fernandez-Sesma A. 2010. Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol 84:4845-4850. http://dx.doi.org/10.1128/JVI.02514-09.
46. Horner SM, Liu HM, Park HS, Briley J, Gale M, Jr. 2011. Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus. Proc Natl Acad Sci U S A 108:14590-14595. http://dx.doi.org/10.1073/pnas.1110133108.
47. Baril M, Racine ME, Penin F, Lamarre D. 2009. MAVS dimer is a crucial signaling component of innate immunity and the target of hepatitis C virus NS3/4A protease. J Virol 83:1299-1311. http://dx.doi.org/10.1128 /JVI.01659-08.
48. Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ. 2011. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146:448-461. http://dx.doi.org/10.1016/j.cell.2011.06.041.
49. Tang ED, Wang CY. 2009. MAVS self-association mediates antiviral innate immune signaling. J Virol 83:3420-3428. http://dx.doi.org/10.1128/JVI.02623-08.
50. Nasirudeen AM, Wong HH, Thien P, Xu S, Lam KP, Liu DX. 2011. RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS Negl Trop Dis 5:e926. http://dx.doi.org/10.1371/journal.pntd.0000926.